Tianjin Medical University Cancer Institute & Hospital: Clinical Trials & Research Profile

Academic Medical Center in Tianjin, China · Primary Specialty: Oncology and Hematology

Clinical Trial MetricVerified Public Record
Organization TypeClinical Trial Research Site
Institutional Sector & LocationAcademic Medical Center (Tianjin, China)
Primary Therapeutic AreaOncology and Hematology
Active Phase II & III Studies170 active (75 recruiting now)
Total Tracked Studies (2018 to 2026)235
Completed vs Early-Stopped Studies24 completed / 11 stopped (4.7% stop rate)
Median Closed Enrollment178 participants
Median Completed Study Duration1,277 calendar days
Physical Hospital Site Disclosure100.0% named hospital campus

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI -> · AI for Healthcare · Healthcare Price & Patent Cliff Crosswalk